Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis
case report
Keywords:
Perivascular epithelioid cell neoplasms, Retroperitoneal neoplasms, Antineoplastic protocolsAbstract
CONTEXT: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors. Adjuvant radio-therapy and/or chemotherapy are administered according to the patient’s clinical characteristics. CASE REPORT: A 42-year-old female patient was operated to treat a retroperitoneal mass. The diagnosis was established as PEComa with benign behavior. Two years after the diagnosis, chest and abdominal computed tomography scans showed intra-abdominal recurrence and lymphangioleiomyomatosis in the lung. Treatment with everolimus was started. The disease stabilized in the third month of treatment, ac-cording to the response evaluation criteria in solid tumors. CONCLUSION: PEComas are tumors with unpredictable behavior. Therefore, these patients require long-term follow-up, even in cases of correct diagnosis and benign PEComa.
Downloads
References
Pata G, Tironi A, Solaini L, Tiziano T, Ragni F. Perivascular epithelioid cell tumor located retroperitoneally with pulmonary lymphangioleiomyomatosis: report of a case. Surg Today. 2014;44(3):572-6.
Zekry N, Rettenmaier MA, Abaid LN, et al. Perivascular epithelioid cell neoplasms: a systematic review of prognostic factors. J Minim Invasive Gynecol. 2009;16(5):527-32.
Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J ClinOncol.2010;28(5):835-40.
Benson C, Vitfell-Rasmussen J, Maruzzo M, et al. A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience. Anticancer Res. 2014;34(7):3663-8.
Gennatas C, Michalaki V, Kairi PV, Kondi-Paphiti A, Voros D. Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor. World J SurgOncol. 2012;10:181.
Wu JH, Zhou JL, Cui Y, et al. Malignant perivascular epithelioid cell tumor of the retroperitoneum. Int J Clin Exp Pathol. 2013;6(10):2251-6.
Koenig AM, Quaas A, Ries T, et al. Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour: a case report. J Med Case Rep. 2009;3:62.
Shin JS, Spillane A, Wills E, Cooper WA. PEComa of the retroperitoneum. Pathology. 2008;40(1):93-5.
Tan Y, Zhang H, Xiao EH. Perivascular epithelioid cell tumour: dynamic CT, MRI and clinicopathological characteristics--analysis of 32 cases and review of the literature. Clin Radiol. 2013;68(6):555-61.
To VYK, Tsang JPK, Yeung TW, Yuen MK. Retroperitoneal sclerosing perivascular epithelioid cell tumour. Hong Kong J Radiol. 2015;18:51-6. Available from: https://www.researchgate.net/publication/273832134_Retroperitoneal_Sclerosing_Perivascular_Epithelioid_Cell_Tumour. Accessed in 2017 (Oct 6).
